Analysts Estimate NovoCure (NVCR) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 02/16/23
Novocure Announces Last Patient Enrolled in Pivotal PANOVA-3 Study of Tumor Treating Fields in Pancreatic CancerBusiness Wire • 02/15/23
Novocure Round-Trips Its Recent Breakout After Announcing A Series Of C-Suite ChangesInvestors Business Daily • 01/19/23
Novocure Has Fallen More Than 20% Over Seven Days — Why It Fell From GraceInvestors Business Daily • 01/17/23
Novocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company UpdateBusiness Wire • 01/09/23
Novocure, Zai shares rally after lung-cancer treatment meets primary endpoint in studyMarket Watch • 01/05/23
Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival EndpointBusiness Wire • 01/05/23